AI-designed intrabodies could unlock new treatments for Alzheimers, Parkinsons and MND

Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimers, Parkinsons, Huntingtons disease, and motor neurone disease.